Valeo Financial Advisors’s Asensus Surgical, Inc. ASXC Stock Holding History

Valeo Financial Advisors’s Portfolio ASXC Stock Details ASXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-854	Closed	-$1K	–	2225
2020 Q4	$1K	Hold	854	–	–	﹤0.01%	1634
2020 Q3	$0	Sell	854 -2,628	-75%	-$1.02K	﹤0.01%	2209
2020 Q2	$2K	Hold	3,482	–	–	﹤0.01%	1817
2020 Q1	$1K	Hold	3,482	–	–	﹤0.01%	1746
2019 Q4	$5K	Buy	3,482 +2,628	+308%	+$9.13K	﹤0.01%	1310
2019 Q3	$7K	Sell	854 -2,626	-75%	-$35.7K	﹤0.01%	1133
2019 Q2	$62K	Hold	3,480	–	–	0.01%	544
2019 Q1	$108K	Hold	3,480	–	–	0.01%	397
2018 Q4	$102K	Hold	3,480	–	–	0.01%	374
2018 Q3	$139K	Buy	3,480 +95	+3%	+$6.43K	0.02%	341
2018 Q2	$209K	Sell	3,385 -165	-5%	-$6.01K	0.03%	275
2018 Q1	$78K	Hold	3,550	–	–	0.01%	407
2017 Q4	$89K	Buy	+3,550	New	+$109K	0.01%	361

Other funds holding ASXC

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Valeo Financial Advisors's ASXC Position: Q1 2021 in Review

Valeo Financial Advisors sold out of Asensus Surgical, Inc. (ASXC) in Q1 2021, closing a stake of 854 shares — an estimated $1K sold.

Valeo Financial Advisors first reported a position in ASXC in Q4 2017 and held it in 13 quarters. The position peaked at $209K in Q2 2018. 100 funds tracked by Wall St. Rank hold ASXC as of Q1 2021.

Valeo Financial Advisors reported no remaining Asensus Surgical, Inc. position as of Q1 2021 after selling out during the quarter.
Valeo Financial Advisors sold 854 Asensus Surgical, Inc. shares in Q1 2021, an estimated $1K.
Valeo Financial Advisors first reported a position in Asensus Surgical, Inc. in Q4 2017 and held it in 13 quarters.
Valeo Financial Advisors's Asensus Surgical, Inc. position peaked at $209K in Q2 2018.
100 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q1 2021.

Based on Valeo Financial Advisors's 13F filing for Q1 2021, filed 12 Apr 2021.